Athletics Sprinter Sanctioned
Sport Integrity Australia acknowledges that Australian Athletics has imposed a three-year period of Ineligibility on athlete Amanda (Mandy) Mason for the Presence and Use of a Prohibited Substance.
Ms Mason returned an Adverse Analytical Finding from an In-Competition doping control test on 13 April 2024.
Ms Mason’s sample was analysed at the Australian Sports Drug Testing Laboratory, part of the National Measurement Institute, and the presence of LGD-4033 (Ligandrol) and LGD-4033 metabolite: Di-hydroxy LGD-4033 was detected.
The substance LGD-4033 (Ligandrol) is classified as Class S1.2 (Other Anabolic Agents) substance under the World Anti-Doping Code — International Standard — Prohibited List 2024 (2024 Prohibited List). LGD-4033 (Ligandrol) is classified as a Non-Specified Substance and is prohibited at all times.
Under Article 10.8.1 of the Australian National Anti-Doping Policy 2021 (ANADP) a one-year reduction in the period of Ineligibility may be applied to an athlete’s period of Ineligibility for certain Anti-Doping Rule Violations based on early admission and acceptance of sanction.
Australian Athletics has therefore imposed a three-year period of Ineligibility on Ms Mason commencing on 13 June 2024.
Ms Mason is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 13 June 2027. She is also not permitted to compete in a non-signatory professional league, or event organised by a non-signatory International or National level event organisation.
Additional information on the Prohibited Substances
LGD-4033 is a Selective Androgen Receptor Modulator (SARM) which is not approved for human use or consumption in Australia. SARMs pose serious health concerns, including increased risk of heart attack, stroke and life-threatening liver toxicity.
SARMs are claimed to be a substances that induce muscle (and bone) growth without the side effects associated with steroid use. However, information on the safety of SARMs is scarce due to a lack of medium and long-term clinical trials.
Anabolic agents pose many threats to an athlete’s health and some side effects may include an increase in blood pressure and cholesterol levels which can lead to heart disease. Liver disease and infertility can also result from the use of these agents.
The Australian Therapeutic Goods Administration (TGA) classifies all SARMs, as a Schedule 4 drug – a prescription-only medicine or animal remedy. The possession of these SARMs without appropriate authority, is illegal.
Learn more about the health effects of doping.
